Foscarnet
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2676 publications
Structural and mechanistic insights into SLC34 phosphate import.
Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026
Delayed-onset cytomegalovirus retinitis after 0.2 µg/day fluocinolone acetonide implantation: a case series.
Journal: Journal of ophthalmic inflammation and infection
Published: May 25, 2026
Human Herpesvirus-6B Encephalitis
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: May 19, 2026
Herpes Simplex Encephalitis
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: May 19, 2026
Intravitreal foscarnet is an effective adjunct after systemic therapy failure in pediatric antiviral-resistant cytomegalovirus retinitis.
Journal: The Journal of international medical research
Published: April 16, 2026
Recurrent CMV Retinitis in a Daratumumab-Treated Multiple Myeloma Patient With Systemic Antiviral Intolerance.
Journal: Retinal cases & brief reports
Published: April 07, 2026
Maribavir for cytomegalovirus retinitis: A case series and review of the literature.
Journal: AJO international
Published: April 06, 2026
Case report:Maribavir for refractory CMV infection in 2 pediatric HSCT recipients.
Journal: Diagnostic microbiology and infectious disease
Published: March 23, 2026
Diagnosis and management of acyclovir-resistant herpes simplex virus for the dermatologist.
Journal: Journal of the American Academy of Dermatology
Published: March 18, 2026
Incidence and clinical characterization of retinal detachment in acute retinal necrosis: a global federated database analysis.
Journal: Frontiers in ophthalmology
Published: March 12, 2026
Case report: Maribavir as salvage therapy for multidrug-resistant CMV DNAemia in a non-transplant patient with ocular cicatricial pemphigoid.
Journal: IDCases
Published: March 07, 2026
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial.
Journal: Frontiers in immunology
Published: March 01, 2026
Last Updated: 06/30/2026